Cargando…

588. Retrospective Analysis of Clinical Characteristics and Treatment Patterns Among HIV Patients with Commercial and Medicare Advantage Health Insurance in the United States

BACKGROUND: With modern antiretroviral (ARV) regimens, HIV infection has evolved into a manageable chronic condition. The ultimate goal of treatment is to maximize the virologic suppression of HIV virus while minimizing intolerability, toxicity, drug-to-drug interactions, and noncompliance. The obje...

Descripción completa

Detalles Bibliográficos
Autores principales:	Priest, Julie, Burton, Tanya, Blauer-Peterson, Cori, Andrade, Katherine, Oglesby, Alan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2018
Materias:	Abstracts
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6254070/ http://dx.doi.org/10.1093/ofid/ofy210.595

Ejemplares similares

1019. Healthcare Resource Utilization and Cost of People Living with HIV (PLWH) in US Commercial and Medicare Advantage Health Plans
por: Priest, Julie, et al.
Publicado: (2020)

Characterization of Heavily Treatment-Experienced People With HIV and Impact on Health Care Resource Utilization in US Commercial and Medicare Advantage Health Plans
por: Priest, Julie, et al.
Publicado: (2021)

Association of Health Insurance Literacy With Enrollment in Traditional Medicare, Medicare Advantage, and Plan Characteristics Within Medicare Advantage
por: Park, Sungchul, et al.
Publicado: (2022)

Use of Telemedicine for Buprenorphine Inductions in Patients With Commercial Insurance or Medicare Advantage
por: Barsky, Benjamin A., et al.
Publicado: (2022)

Trends in Testosterone Prescriptions for Older Men Enrolled in Commercial Insurance and Medicare Advantage
por: Everhart, Alexander, et al.
Publicado: (2021)

Comparison of Diabetes Medications Used by Adults With Commercial Insurance vs Medicare Advantage, 2016 to 2019
por: McCoy, Rozalina G., et al.
Publicado: (2021)

Trends in opioid use in commercially insured and Medicare Advantage populations in 2007-16: retrospective cohort study
por: Jeffery, Molly Moore, et al.
Publicado: (2018)

Cost trends among commercially insured and Medicare Advantage-insured patients with chronic obstructive pulmonary disease: 2006 through 2009
por: Dalal, Anand A, et al.
Publicado: (2011)

Prescription Drug Coverage for Treatment of Low Back Pain Among US Medicaid, Medicare Advantage, and Commercial Insurers
por: Lin, Dora H., et al.
Publicado: (2018)

Patterns of Comorbidity and Multimorbidity Among Patients With Multiple Sclerosis in a Large US Commercially Insured and Medicare Advantage Population
por: Dai, Dingwei, et al.
Publicado: (2022)

2512. Decreasing Adherence to Antiretroviral Therapy over 4 Years of Follow-up in a Commercially-Insured Population of Patients with HIV
por: Priest, Julie, et al.
Publicado: (2019)

Compared to commercially insured patients, Medicare advantage patients adopt newer diabetes drugs more slowly and adhere to them less
por: Flory, James H, et al.
Publicado: (2021)

Burden of illness and costs associated with eosinophilic granulomatosis with polyangiitis: evidence from a managed care database in the United States
por: Bell, Christopher F, et al.
Publicado: (2021)

Comparison of Ambulatory Care Access and Quality for Beneficiaries With Disabilities Covered by Medicare Advantage vs Traditional Medicare Insurance
por: Johnston, Kenton J., et al.
Publicado: (2022)

Evaluation of Potentially Avoidable Acute Care Utilization Among Patients Insured by Medicare Advantage vs Traditional Medicare
por: Beckman, Adam L., et al.
Publicado: (2023)

Patient Perspectives on the Burden of Heart Failure with Preserved Ejection Fraction in a US Commercially Insured and Medicare Advantage Population: A Survey Study
por: Nguyen, Chi, et al.
Publicado: (2023)

Characteristics of Terminated Medicare Advantage Contracts, 2011 to 2020
por: Meyers, David J., et al.
Publicado: (2022)

How Do the Hospital Prices Paid by Medicare Advantage Plans and Commercial Plans Compare With Medicare Fee-for-Service Prices?
por: Maeda, Jared Lane K., et al.
Publicado: (2018)

Comorbidity Associations with AATD Among Commercially Insured and Medicare Beneficiaries with COPD in the US
por: Sandhaus, Robert, et al.
Publicado: (2020)

Increasing Trends in the Use of Hospital Observation Services for Older Medicare Advantage and Privately Insured Patients
por: Lind, Keith D., et al.
Publicado: (2017)

Can Insurance Market Competition Coexist With Provider Price Regulation? Evidence From Medicare Advantage
por: Berenson, Robert A., et al.
Publicado: (2019)

Mispricing in the Medicare Advantage Risk Adjustment Model
por: Chen, Jing, et al.
Publicado: (2015)

Evaluation of Spending Differences Between Beneficiaries in Medicare Advantage and the Medicare Shared Savings Program
por: Parikh, Ravi B., et al.
Publicado: (2022)

The Association between Medicare Advantage Market Penetration and Diabetes in the United States
por: Howard, Steven W., et al.
Publicado: (2015)

Effect of Medicare Advantage Payments on Dually Eligible Medicare Beneficiaries
por: Atherly, Adam, et al.
Publicado: (2005)

Utilization of an Integrated Medicare Advantage Model Is Positively Associated With Medication Adherence
por: Smith-Ray, Renae, et al.
Publicado: (2020)

National trends in emergency conditions through the Omicron COVID‐19 wave in commercial and Medicare Advantage enrollees
por: Stevens, Maria A., et al.
Publicado: (2023)

Improving Affordability and Equity in Medicare Advantage
por: Song, Zirui, et al.
Publicado: (2019)

Medicare advantage and dialysis facility choice
por: Marr, Jeffrey, et al.
Publicado: (2023)

More surgery in December among US patients with commercial insurance is offset by unrelated but lesser surgery among patients with Medicare insurance
por: Dexter, Franklin, et al.
Publicado: (2022)

PO-05-187 DOES COVID-19 INCREASE THE RISK OF ATRIAL FIBRILLATION? A RETROSPECTIVE ANALYSIS OF A LARGE ADMINISTRATIVE CLAIMS DATABASE OF COMMERCIALLY INSURED NON-ELDERLY AND MEDICARE ADVANTAGE BENEFICIARIES IN THE UNITED STATES.
por: Berman, Adam E., et al.
Publicado: (2023)

Estimates of diagnosed dementia prevalence and incidence among diverse beneficiaries in traditional Medicare and Medicare Advantage
por: Haye, Sidra, et al.
Publicado: (2023)

Estimating Medicare Advantage Lock-In Provisions Impact on Vulnerable Medicare Beneficiaries
por: Laschober, Mary
Publicado: (2005)

Comparison of the Pathway to Hospice Enrollment Between Medicare Advantage and Traditional Medicare
por: Ankuda, Claire K., et al.
Publicado: (2023)

Treatment and persistence with oral anticoagulants among newly diagnosed patients with non-valvular atrial fibrillation: a retrospective observational study in a US commercially insured and Medicare Advantage population
por: Willey, Vincent, et al.
Publicado: (2018)

Multimorbidity and Its Associations With Anxiety and Depression Among Newly Diagnosed Patients With Breast Cancer: A Retrospective Observational Cohort Study in a US Commercially Insured and Medicare Advantage Population
por: Dai, Dingwei, et al.
Publicado: (2022)

Incidence and prevalence of idiopathic inflammatory myopathies among commercially insured, Medicare supplemental insured, and Medicaid enrolled populations: an administrative claims analysis
por: Smoyer-Tomic, Karen E, et al.
Publicado: (2012)

Comparison of Out-of-Pocket Spending on Ultra-Expensive Drugs in Medicare Part D vs Commercial Insurance
por: DiStefano, Michael J., et al.
Publicado: (2023)

663. Characteristics, Treatment Patterns, and Outcomes of Outpatients With Rickettsial Diseases in a Large, Commercially Insured Population: United States, 2005–2016
por: Binder, Alison, et al.
Publicado: (2018)

Comparison of Low-Value Services Among Medicare Advantage and Traditional Medicare Beneficiaries
por: Boudreau, Emily, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_527c38fspfbog83mggs4h1mk7l